{
    "startDate": "2017-01-01",
    "endDate": "2017-12-31",
    "year": "2017",
    "quarter": "FY",
    "symbol": "CRIS",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 38288000
            },
            {
                "label": "Investments",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 21944000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 3073000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 989000
            },
            {
                "label": "Current Assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 64294000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 400000
            },
            {
                "label": "Long-term investment\u2014restricted",
                "concept": "RestrictedInvestmentsNoncurrent",
                "unit": "usd",
                "value": 153000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 9000000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 3000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 73798000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 5423000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2793000
            },
            {
                "label": "Current portion of long-term debt, net",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 5900000
            },
            {
                "label": "Current Liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 14102000
            },
            {
                "label": "Long-term debt, net",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 35669000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 34000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 49805000
            },
            {
                "label": "Common stock, $0.01 par value\u2014225,000,000 shares authorized at December 31, 2017 and 2016, respectively; 165,379,967 shares issued and 164,157,121 shares outstanding at December 31, 2017, respectively; 142,346,871 shares issued and 141,124,025 shares outstanding at December 31, 2016",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 1654000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 976130000
            },
            {
                "label": "Treasury stock (at cost, 1,222,846 shares at December 31, 2017 and 2016, respectively)",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 1524000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -952265000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -2000
            },
            {
                "label": "Stockholders\u2019 Equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 23993000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 73798000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -53317000
            },
            {
                "label": "Depreciation and amortization expense",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 235000
            },
            {
                "label": "Number of Shares",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 5359000
            },
            {
                "label": "Issuance of common stock in consideration for rights granted under the Aurigene collaboration agreement (see Note 3(b))",
                "concept": "cris:IssuanceOfCommonStockToLicensees",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Amortization of debt issuance costs",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 144000
            },
            {
                "label": "Non-cash interest (income)/expense",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": 53000
            },
            {
                "label": "Gain on sale of fixed assets",
                "concept": "GainLossOnDispositionOfAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 614000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -267000
            },
            {
                "label": "Accounts payable and accrued and other liabilities",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -376000
            },
            {
                "label": "Adjustments to reconcile net loss to net cash used in operating activities:",
                "concept": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 4962000
            },
            {
                "label": "Cash Flows from Operating Activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -48355000
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 51121000
            },
            {
                "label": "Sales/maturities of investments",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 47679000
            },
            {
                "label": "Decrease in restricted cash/investments",
                "concept": "IncreaseDecreaseInRestrictedCash",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Expenditures for property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 188000
            },
            {
                "label": "Proceeds from sale of fixed assets",
                "concept": "ProceedsFromSaleOfProductiveAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash Flows from Investing Activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -3630000
            },
            {
                "label": "Net proceeds from sale of shares",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 41546000
            },
            {
                "label": "Proceeds from issuance of common stock under the Company\u2019s share-based compensation plans",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
                "unit": "usd",
                "value": 1138000
            },
            {
                "label": "Proceeds from new credit agreement with HealthCare Royalty",
                "concept": "ProceedsFromLongTermLinesOfCredit",
                "unit": "usd",
                "value": 45000000
            },
            {
                "label": "Payment of debt issuance costs",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 192000
            },
            {
                "label": "Payment on termination of former credit agreement with BioPharma",
                "concept": "RepaymentsOfLongTermLinesOfCredit",
                "unit": "usd",
                "value": 18303000
            },
            {
                "label": "Payments made on Curis Royalty\u2019s debt",
                "concept": "RepaymentsOfDebt",
                "unit": "usd",
                "value": 4954000
            },
            {
                "label": "Cash Flows from Financing Activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 64235000
            },
            {
                "label": "Net increase/(decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 12250000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaid",
                "unit": "usd",
                "value": 3942000
            }
        ],
        "ic": [
            {
                "label": "Royalties",
                "concept": "RoyaltyRevenue",
                "unit": "usd",
                "value": 9849000
            },
            {
                "label": "Research and development, net",
                "concept": "cris:ResearchAndDevelopmentRevenueNet",
                "unit": "usd",
                "value": 49000
            },
            {
                "label": "Revenues:",
                "concept": "Revenues",
                "unit": "usd",
                "value": 9898000
            },
            {
                "label": "Cost of royalty revenues",
                "concept": "RoyaltyExpense",
                "unit": "usd",
                "value": 496000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 45096000
            },
            {
                "label": "In-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 14066000
            },
            {
                "label": "Costs and Expenses:",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 59658000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -49760000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 513000
            },
            {
                "label": "Other (expense) income",
                "concept": "OtherIncome",
                "unit": "usd",
                "value": -104000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 3966000
            },
            {
                "label": "Total other expense, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -3557000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -53317000
            },
            {
                "label": "Net Loss per Common Share (Basic and Diluted) (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.36
            },
            {
                "label": "Weighted Average Common Shares (Basic and Diluted) (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 149133466
            },
            {
                "label": "Unrealized gain/(loss) on marketable securities",
                "concept": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -53315000
            }
        ]
    }
}